R83.6
Abnormal cytological findings in cerebrospinal fluid
Clinical Classification Guidelines
Medical Intelligence & Overview
Abnormal cytological findings in cerebrospinal fluid (CSF) refer to the presence of unusual cells or changes in cell appearance detected through laboratory analysis of CSF, a clear fluid surrounding the brain and spinal cord. These findings can provide valuable clues about underlying health conditions, including infections, inflammations, or malignancies affecting the central nervous system (CNS). The ICD-10 code R83.6 is assigned when such abnormal results are observed during routine or targeted testing of CSF. Recognizing and understanding these abnormalities is crucial for guiding further medical evaluation and management.
Causes & Symptoms
Clinical Causes: Infections such as meningitis or encephalitis caused by bacteria, viruses, fungi, or parasites Inflammatory conditions including multiple sclerosis or autoimmune disorders affecting the CNS Neoplastic diseases like primary or metastatic brain tumors, or lymphoma involving the CNS Bleeding into the cerebrospinal fluid due to hemorrhage or trauma Degenerative neurological diseases causing cellular changes in CSF Other conditions causing cellular atypia or abnormal cytology in CSF samples
Key Symptoms: Headache Neck stiffness or pain Fever Altered mental status or confusion Nausea or vomiting Sensory or motor changes Seizures Symptoms specific to underlying conditions (e.g., vision changes in multiple sclerosis)
Diagnostic & Treatment
Diagnosis Path: The process of diagnosing abnormal cytological findings in CSF involves several steps:
Treatment Protocols: Treatment options depend on the underlying cause identified through diagnostic testing:
Clinical Advice & FAQs
Billing Guidance
Is R83.6 a billable ICD-10 code?
Yes, R83.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R83.6?
Clinical documentation must specify the nature of Abnormal cytological findings in cerebrospinal fluid and any associated comorbidities for accurate reporting.
Cite this Clinical Reference